TrialClinical pharmacokinetics2025

Population Cellular Kinetics of Idecabtagene Vicleucel in Patients with Triple-Class-Exposed Relapsed/Refractory Multiple Myeloma.

Fan Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.